For health care professionals in EUROPE except those practicing in France as the following pages are intended to all International health care professionals and are not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Other health care professionals should select their country in the top right corner of the website.
Please note that the following pages are exclusively reserved for health care professionals in countries with applicable health authority product registrations. To the extent this site contains information, reference guides and databases intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labeling for prescriptive information and operating instructions.
This Website is protected by the laws on copyright and by the relevant international conventions. It is strictly forbidden to make copies, whether partial or total and on whichever media without prior approval.
AGENT™
Drug-Coated Balloon
Enhanced Coating Integrity
Balanced hydrophobic and hydrophilic properties of TransPaxTM coating, ensures DCB reaches the lesions with the optimal amount of drug for your patient.
Fewer particulates are lost distally during the procedure3
AGENT™ Drug-Coated Balloon generates significant fewer drug particulates lost downstream than showed competitors3.
All particulates from insertion, delivery, inflation/deflation, and withdrawal captured on 5 µm filter. In this study, DCBs are delivered in the coronary track model with fluid recirculation. Particulates lost downstream are collected with a Polycarbonate filter and shown here as green dots3.
Coating Transfer
Coating durability is one of the most important factors of a drug coating. If the coating is not durable, there is risk that drug will come off the balloon during the track to the lesion4. Our excipient, acetyl tributyl citrate - ATBC, has a balance of hydrophilic and hydrophobic properties which maintains coating integrity and optimises adhesion to the balloon2 but also allows the coating to transfer to the vessel wall from the balloon during inflation1. The presence of an excipient is critical to achieve desired tissue levels as the excipient modulates the release of the drug.
